Obewise 5 Tablet is a specialized pharmaceutical formulation containing Obeticholic acid at a concentration of 5 mg per tablet. Obeticholic acid is a synthetic bile acid derivative that plays a significant role in the management of liver diseases, particularly primary biliary cholangitis (PBC). This medication functions by activating the farnesoid X receptor (FXR), which is crucial for regulating bile acid synthesis and transport, thereby improving liver function and mitigating the progression of liver damage.
Obewise 5 is primarily indicated for the treatment of patients diagnosed with primary biliary cholangitis, a chronic autoimmune disorder characterized by the gradual destruction of bile ducts in the liver. By enhancing bile flow and reducing the accumulation of toxic bile acids, Obeticholic acid helps alleviate symptoms associated with liver dysfunction, such as fatigue, itching (pruritus), and jaundice. Furthermore, it may improve liver histology and slow the progression of fibrosis in patients with advanced liver disease, making it an essential component of therapy for individuals with PBC.
The administration of Obewise 5 is typically oral, and the dosage may vary based on the individual’s condition and response to treatment. It is crucial for patients to adhere to their healthcare provider's instructions regarding dosage and duration of therapy. While Obewise 5 is generally well-tolerated, some patients may experience side effects, including abdominal discomfort, nausea, diarrhea, and elevated liver enzymes. Regular monitoring of liver function tests is recommended to ensure the safety and effectiveness of the treatment.
For optimal storage, Obewise 5 should be kept in a cool, dry place, away from direct sunlight and moisture. It is important to store the medication in its original packaging and out of reach of children to prevent accidental ingestion.